Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Severe hair loss is linked to worse COVID-19 outcomes, especially in younger men.

Most severe COVID-19 patients had hair loss, suggesting a possible link.

Androgenetic alopecia, or hair loss, is influenced by hormones and genetics, and can be treated with medications like minoxidil, finasteride, or hormone therapy, with effectiveness evaluated after 6 months.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

Pattern hair loss is the most common type of alopecia.

Diagnosing Sertoli-Leydig cell tumors is challenging due to their unusual symptoms and can occur at any age.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

Scalp hair grows at 0.37 mm/day, forearm hair at 0.18 mm/day, and thigh hair at 0.30 mm/day, with no significant differences found in people with certain hair conditions.

Minoxidil helps stabilize hair loss, increase density, and reduce shedding after hair transplant surgery.

Different ethnic groups have unique hair growth patterns, with African hair growing slower and less dense, Asian hair growing fast but sparse, and Caucasian hair being densest; men are more likely to experience hair loss than women.

Some plant-based chemicals may help with hair growth, but more research is needed to confirm their effectiveness.

The first in-prison dermatology clinic in the U.S. faced challenges and found certain skin conditions common among inmates, with rare cases of serious skin cancer.

Most white Spanish women have a widow's peak, and their hairline measurements could help in hair restoration surgery.

Common baldness is likely inherited through multiple genes, not just one.

Hair shedding increases at the end of summer due to seasonal changes.

Some breast cancer chemotherapy can cause permanent hair loss.

Hair loss from genetics and hormones can be treated with drugs or surgery.

AAG causes hair loss in many people, with limited treatments like finasteride, minoxidil, light therapy, and hair transplants.

PRP therapy may help reduce hair loss and increase hair density in androgenetic alopecia.

Androgenetic alopecia is common hair loss caused by genetics and hormones, with treatments mainly slowing it down.

Androgenetic alopecia is common hair loss caused by genetics and hormones, with treatments to slow it but no cure.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Androgenetic alopecia is influenced by multiple genes and pathways, with genetic risk varying by population, and personalized treatments are being explored.

Trichoscopy is useful for diagnosing and assessing androgenetic alopecia severity.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Photobiomodulation can improve hair density and thickness, but it's costly and needs more research.

Female pattern hair loss treatments vary in effectiveness and may have side effects.

Treat hair loss in postmenopausal women with diet, avoiding certain drugs, and using medications like minoxidil or finasteride.